🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate bioequivalence of a 2.5 mg saxagliptin/1000 mg metformin (gl...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00897390
Treatments Being Tested
SMART Study - A 24-Week, Multicenter, Randomized, Parallel-group, Open-labe...
Status
Completed
Location
Research Site
Start Date
2014-09
Trial ID
NCT02243176
Treatments Being Tested
Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Status
Terminated
Location
Gastroenterology Department Erasme Hospital
Start Date
2014-10
Trial ID
NCT02244164
Treatments Being Tested
This study will evaluate the efficacy and tolerability of saxagliptin compa...
Status
Completed
Location
Research Site
Start Date
2009-10
Trial ID
NCT01006603
Treatments Being Tested
Study in healthy subjects to measure amount of drug in blood after dosing w...
Status
Completed
Location
Research Site
Start Date
2011-10
Trial ID
NCT01441869
The primary objective of this study is to assess the pharmacokinetic parame...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01755494
Study will evaluate if a combination of saxagliptin and dapagliflozin added...
Status
Completed
Location
Research Site
Start Date
2014-09-09
Trial ID
NCT02284893
Study Hypothesis：Compared with premixed insulin, triple oral combination th...
Status
Completed
Location
The Pearl River Hospital of Southern Medical University
Start Date
2018-10-01
Trial ID
NCT03700801
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
The study purpose is to assess adverse events in patients with Type 2 diabe...
Status
Terminated
Location
Local Institution
Start Date
2013-10
Trial ID
NCT01944618
Treatments Being Tested